Bausch & Lomb
VC Fund
Rochester, United States
Bausch & Lomb is a VC fund in Rochester focused on Health Care and Biotechnology. Bausch + Lomb is the eye health company dedicated to Bringing Visionary Ideas to Eye Health.They offer the world’s most comprehensive portfolio of eye health products, and They have one of the oldest, best known and most respected healthcare brands in the world.The company began in 1853 in Rochester, New York, as a small optical shop thatgrew to become a multi-billion dollar corporation with approximately 13,000 employees worldwide, and with products available in more than 100 countries.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 43%
Last updated:
For AI agents: llms.txt
Industries Bausch & Lomb invests in
Stages Bausch & Lomb invests in
Countries Bausch & Lomb invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Robert Bertolini
|
|||
Bob Palmisano
|
|||
Chad Speegle
|
|||
Joseph Landy
|
Investment Focus
Industry
- Health Care 3 (43%)
- Biotechnology 2 (29%)
- Medical 1 (14%)
- Therapeutics 1 (14%)
- Medical Device 1 (14%)
Stage
- Grant 1 (14%)
- Series B 1 (14%)
- Series D 1 (14%)
- Series G 1 (14%)
- Funding Round 1 (14%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Brenton Saunders
Chief Executive Officer
|
Chief Executive Officer | Total investments: 9 | Find email | |
|
Robert Bertolini
President & CFO
|
President & CFO | Total investments: 0 | Find email | |
|
Bob Palmisano
Executive
|
Executive | Total investments: 0 | Find email | |
|
Chad Speegle
Territory Manager
|
Territory Manager | Total investments: 0 | Find email | |
|
Joseph Landy
Director
|
Director | Total investments: 5 | Find email | |
| See all 11 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Emmecell
|
Emmecell is a biotechnology company that provides developing cell-based therapies. | Corporate Round / Jun 16, 2026 | |
Character Biosciences
|
Biopharmaceutical research and development company that's an affiliate of Clover Health | $93M / Series B / Mar 25, 2025 | |
The Seeing Eye
|
The Seeing Eye is a donation based company that trains and provides seeing eye canines alongside owner training for blind individuals. | $25K / Grant / Mar 18, 2024 | |
AcuFocus
|
Acufocus, Inc., a medical device company, engages in the research, development, and marketing of solutions for the treatment of presbyopia. The company develops KAMRA, a corner inlay for the treatment of near vision loss that allows patients to see near and intermediate objects clearly; and AcuTarget, a system that is used to guide surgeons onsurgical placement of the KAMRA.It was founded in 2011 and headquartered in Irvine, California. | $21M / Sep 03, 2014 | |
|
AcuFocus
|
Acufocus, Inc., a medical device company, engages in the research, development, and marketing of solutions for the treatment of presbyopia. The company develops KAMRA, a corner inlay for the treatment of near vision loss that allows patients to see near and intermediate objects clearly; and AcuTarget, a system that is used to guide surgeons onsurgical placement of the KAMRA.It was founded in 2011 and headquartered in Irvine, California. | $21M / Series G / Sep 03, 2014 | |
|
AcuFocus
|
Acufocus, Inc., a medical device company, engages in the research, development, and marketing of solutions for the treatment of presbyopia. The company develops KAMRA, a corner inlay for the treatment of near vision loss that allows patients to see near and intermediate objects clearly; and AcuTarget, a system that is used to guide surgeons onsurgical placement of the KAMRA.It was founded in 2011 and headquartered in Irvine, California. | $65M / Private Equity / Nov 29, 2011 | |
|
AcuFocus
|
Acufocus, Inc., a medical device company, engages in the research, development, and marketing of solutions for the treatment of presbyopia. The company develops KAMRA, a corner inlay for the treatment of near vision loss that allows patients to see near and intermediate objects clearly; and AcuTarget, a system that is used to guide surgeons onsurgical placement of the KAMRA.It was founded in 2011 and headquartered in Irvine, California. | $18M / Series D / Jan 26, 2007 |
Co-Investors
Accuitive Medical Ventures
4 deals together
SV Health Investors
4 deals together
The Carlyle Group
4 deals together
Versant Ventures
4 deals together
HealthCare Royalty Partners
3 deals together
Medtronic
3 deals together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Bausch & Lomb invest in?
Bausch & Lomb invests primarily in Health Care, Biotechnology and Medical startups, most often at Grant and Series B stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Bausch & Lomb?
Public channels for Bausch & Lomb include X (Twitter), the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Bausch & Lomb?
The team at Bausch & Lomb includes Brenton Saunders (Chief Executive Officer), Robert Bertolini (President & CFO) and Bob Palmisano (Executive), among 11 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
